Olopatadine Hydrochloride (Sandoz Inc.)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Sandoz Inc.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | olopatadine hydrochloride |
SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-04-01 |
END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Olopatadine Hydrochloride from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 665(ug/100uL) |
START MARKETING DATE: | 2015-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-320_313644e5-b24e-a6d0-e384-6f59ccc2f441 |
PRODUCT NDC: | 61314-320 |
APPLICATION NUMBER: | NDA021861 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: